Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ABS-205 to be studied as potential Alzheimer's disease treatment

March 6, 2000

Sweden approves Shire's AD treatment agent

March 6, 2000

Asahi discloses 2,3-dihydrobenzofurans for emesis, etc.

March 6, 2000

Noven successfully completes phase II study of MethyPatch for treatment of ADHD

March 3, 2000

Novantrone moves one step closer to approval for MS

March 3, 2000

Estrogen protects against brain damage from ischemic insult in female rats

March 3, 2000

U.S./Russian investigators present anesthetics with useful hypometabolic, cardiovascular effects

March 3, 2000

Pharmaceutically useful neuroprotective agents emerge from R&D at Cambridge NeuroScience

March 3, 2000

Guilford to develop novel propofol prodrug discovered by ProQuest

March 3, 2000

Ampakine-like compounds and their use described by Lilly

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...